Author

F. Oladunni

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Biophysics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Research Focus:protein structure prediction· 1 Assay:structural biology· 1 Organism:virus· 1

Frequent Co-Authors

J.-G. Park· 5 shared L. Martinez-Sobrido· 5 shared C. Ye· 3 shared J. B. Torrelles· 2 shared K. Chiem· 2 shared R. N. Platt· 2 shared T. Anderson· 2 shared A. Ahkter· 1 shared

Activity by Year

2020-2021 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersMicrobiology

J.-G. Park

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents

H. Zarkoob, A. Allue-Guardia, Y.-C. Chen, O. Jung, A. G. Vilanova, M. Song, J.-G. Park, F. Oladunni, J. Miller, Y.-T. Tung, I. Kosik, D. Schultz, j. yewdell, J. B. Torrelles, L. Martinez-Sobrido, , E. M. Lee

The paper validates in vitro human lung tissue models for studying SARS-CoV-2 and influenza virus infections and antiviral treatments.

bioRxiv · May 11, 2021Microbiology

Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters

M. S. Piepenbrink, J.-G. Park, F. Oladunni, A. Deshpande, M. Basu, S. Sarkar, A. Loos, J. Woo, P. Lovalenti, D. Sloan, C. Ye, K. Chiem, N. B. Erdmann, P. A. Goepfert, V. L. Truong, , J. J. Kobie

This study evaluates an inhaled monoclonal antibody against SARS-CoV-2 in hamsters, showing reduced viral burden and lung pathology with low-dose inhalation.

bioRxiv · Oct 14, 2020Immunology

Rescue of SARS-CoV-2 from a single bacterial artificial chromosome

C. Ye, J.-G. Park, F. Oladunni, R. N. Platt, T. Anderson, F. Almazan, J. C. de la Torre, L. Martinez-Sobrido

The paper develops an infectious SARS-CoV-2 cDNA clone using a bacterial artificial chromosome, which replicates similarly to the natural virus in cell cultures and animal models.

bioRxiv · Jul 22, 2020Microbiology

Lethality of SARS-CoV-2 infection in K18 human angiotensin converting enzyme 2 transgenic mice

F. Oladunni, J.-G. Park, P. Pino Tamayo, O. Gonzalez, A. Ahkter, A. Allue Guardia, A. Olmo-Fontanez, S. Gautam, A. Garcia Vilanova, C. Ye, K. Chiem, C. Headley, V. Dwivedi, L. Parodi, K. Alfson, , J. B. Torrelles

This study demonstrates that K18 hACE2 transgenic mice are susceptible to SARS-CoV-2 infection, exhibit cytokine and chemokine storms, and serve as a model for studying viral pathogenesis and therapeutic development.

bioRxiv · Jul 18, 2020Microbiology

Structural Basis of RNA Cap Modification by SARS-CoV-2 Coronavirus

T. Viswanathan, S. Arya, S.-H. Chan, S. Qi, N. Dai, R. A. Hromas, J.-G. Park, F. Oladunni, L. Martinez-Sobrido, Y. K. Gupta

The paper reports the high-resolution structure of SARS-CoV-2 nsp16/nsp10 complex during mRNA cap methylation, revealing conformational changes and a novel ligand-binding site for antiviral targeting.

bioRxiv · Apr 26, 2020Biophysics